Sandoz Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sandoz Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012242
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biotechnology-based products known as biosimilars. The company also provides intermediary products including active pharmaceutical ingredients (APIs), as well as biotechnology manufacturing services to other companies. It provides active ingredients and finished dosage forms of pharmaceuticals in the areas of dermatology, cancer, cardiovascular, respiratory, metabolism, central nervous system (CNS), pain, ophthalmic, gastrointestinal and hormonal therapies. Sandoz distributes its products to wholesalers, pharmacies, hospitals and other healthcare outlets. Sandoz is headquartered in Princeton, New Jersey, the US.

Sandoz Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sandoz Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sandoz Inc, Medical Devices Deals, 2011 to YTD 2017 9
Sandoz Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sandoz Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Fougera Pharma Acquires US Rights to Veregen from Medigene 11
Partnerships 12
Accelis Pharma Enters into Distribution Agreement with Fougera Pharma 12
Medicines Company Enters into Distribution Agreement with Sandoz for Angiomax 13
Fougera Pharma Enters into Co-Promotion Agreement with Women’s Choice Pharma for Veregen 14
PharmaDerm and MediGene Enter into Agreement with Women’s Choice Pharma 15
Anacor Pharma Amends Co-Marketing Agreement with Sandoz for Kerydin 16
Licensing Agreements 18
Sandoz and Beximco Pharma Enter into Licensing Agreement with Medicines Patent Pool 18
Vectura Group Enters Into Licensing Agreement With Sandoz For VR315 19
BioQuiddity Expands Licensing Agreement with Sandoz 20
Asset Transactions 21
Shanghai Fosun Pharma Plans to Acquire Medicine Products from Sandoz for USD18 Million 21
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 22
Acquisition 23
Novartis Completes Acquisition Of Fougera Pharma, Dermatology Company, For US$1.5 Billion 23
Sandoz Inc – Key Competitors 25
Sandoz Inc – Key Employees 26
Sandoz Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Strategy And Business Planning 28
Oct 16, 2017: Novartis to Shut Broomfield Generics Manufacturing Unit, Eliminate 450 Jobs 28
Jun 20, 2016: Sandoz Announced Plans for Five Major Global Biosimilar Launches by 2020 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Sandoz Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sandoz Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sandoz Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Sandoz Inc, Medical Devices Deals, 2011 to YTD 2017 9
Sandoz Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fougera Pharma Acquires US Rights to Veregen from Medigene 11
Accelis Pharma Enters into Distribution Agreement with Fougera Pharma 12
Medicines Company Enters into Distribution Agreement with Sandoz for Angiomax 13
Fougera Pharma Enters into Co-Promotion Agreement with Women’s Choice Pharma for Veregen 14
PharmaDerm and MediGene Enter into Agreement with Women’s Choice Pharma 15
Anacor Pharma Amends Co-Marketing Agreement with Sandoz for Kerydin 16
Sandoz and Beximco Pharma Enter into Licensing Agreement with Medicines Patent Pool 18
Vectura Group Enters Into Licensing Agreement With Sandoz For VR315 19
BioQuiddity Expands Licensing Agreement with Sandoz 20
Shanghai Fosun Pharma Plans to Acquire Medicine Products from Sandoz for USD18 Million 21
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 22
Novartis Completes Acquisition Of Fougera Pharma, Dermatology Company, For US$1.5 Billion 23
Sandoz Inc, Key Competitors 25
Sandoz Inc, Key Employees 26
Sandoz Inc, Other Locations 27
Sandoz Inc, Subsidiaries 27

★海外企業調査レポート[Sandoz Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evraz Plc:企業のM&A・事業提携・投資動向
    Evraz Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evraz Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • BrightSpring Health Services:企業の戦略・SWOT・財務分析
    BrightSpring Health Services - Strategy, SWOT and Corporate Finance Report Summary BrightSpring Health Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Grupo Aeroportuario del Sureste SAB de CV:戦略・SWOT・企業財務分析
    Grupo Aeroportuario del Sureste SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Sureste SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Mitsubishi Heavy Industries, Ltd.:企業の戦略・SWOT・財務情報
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • TechnipFMC Plc.:企業の戦略・SWOT・財務分析
    TechnipFMC Plc. - Strategy, SWOT and Corporate Finance Report Summary TechnipFMC Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Eddie Stobart Logistics Plc
    Eddie Stobart Logistics Plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kiewit Corp:企業の戦略的SWOT分析
    Kiewit Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Salesforce.Com Inc (CRM):企業の財務・戦略的SWOT分析
    Salesforce.Com Inc (CRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PT Central Proteina Prima Tbk (CPRO)
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • D4t4 Solutions Plc (ISL):企業の財務・戦略的SWOT分析
    Summary D4t4 Solutions Plc (D4t4), formerly IS Solutions Plc, is an information technology service provider company. The company provides services such as data collection, data management, data analytics, and data solutions. D4t4 offers analytics and reporting; enterprise content management, web and …
  • Sothema (SOT):企業の財務・戦略的SWOT分析
    Sothema (SOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • ShanPar Industries Pvt. Ltd.:戦略・SWOT・企業財務分析
    ShanPar Industries Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary ShanPar Industries Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Avantium NV (AVTX):企業の財務・戦略的SWOT分析
    Avantium NV (AVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • ITOCHU Corporation:企業の戦略・SWOT・財務情報
    ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report Summary ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Serum Institute of India Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Serum Institute of India Ltd (Serum Institute) is a biotechnology company that manufactures and markets vaccines and immuno-biologicals. The company offers products such as bacterial vaccines, viral vaccines, recombinant and combination vaccines, polysaccharide conjugate vaccines, meningococ …
  • Cabela’S Inc:企業の戦略・SWOT・財務分析
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ajinomoto Co Inc (2802):企業の財務・戦略的SWOT分析
    Ajinomoto Co Inc (2802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Consolidated Edison Inc (ED):石油・ガス:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • Promaxo Inc:医療機器:M&Aディール及び事業提携情報
    Summary Promaxo Inc (Promaxo) is a medical device company with focus on the development of portable MRI and other technology. The company develops and commercializes office-based, portable magnetic resonance imaging (MRI) devices that possess cellular spatial resolution, besides targeted biopsy and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆